Please assess the completion status of the following clinical trial:

Trial Title: The Effect of Different Types of Progestin on Sleeping of Menopausal Women

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* new menopausal patients at Maharaj Nakorn Chiang Mai Hospital~* suitable for estrogen plus progesterone treatment~Exclusion Criteria:~* contraindication for hormone replacement therapy~* recently used sleep enhancing medicine~* recently used psychotic medicine

- Gender: FEMALE
- Minimum Age: 40 Years
- Maximum Age: 65 Years
- Healthy Volunteers: t

Study Arms:
- micronized progesterone (Type: EXPERIMENTAL): 1 mg 17 beta-estradiol plus 100 mg micronized progesterone taken orally once a day for 3 months.
- dydrogesterone (Type: EXPERIMENTAL): 1mg 17 beta-estradiol plus 10 mg dydrogesterone taken orally once a day for 3 months.

Based on this trial design, predict the completion outcome and termination type (if applicable).